Tagdirect-acting antiviral agents (DAAs)

‘I’m over the moon!’: patient-perceived outcomes of hepatitis C treatment

I’m over the moon!’: patient-perceived outcomes of hepatitis C treatment Davoud Pourmarzi, Andrew Smirnov, Lisa Hall, Gerard FitzGerald, and Tony Rahman Australian Journal of Primary Health 26(4) 319-324 Submitted: 22 January 2020  Accepted: 29 April 2020   Published: 25 June 2020 Abstract Understanding patient-perceived outcomes is crucial for assessing the effectiveness and acceptability of...

What’s new in HIV and hep C? An update for Aboriginal and Torres Strait Islander health workers

W

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), June 2019 This Deadly Sex Update webinar provides Aboriginal and Torres Strait Islander health and community workers with an introduction and the latest news in hepatitis C and HIV. The information presented supports health workers to discuss key messages with clients and the community around hep C and HIV, including...

Hepatitis C – Peer insights on barriers and motivators to Direct-Acting Antiviral (DAA) treatment uptake

H

ARCSHS, 2018 The knowledge and experience of people who inject drugs (PWID) within peer programs is a vital asset to strategies for the scale-up of DAA treatment among PWID (Brown and Reeders, 2016). This study is focused on translating these “real time” peer insights into resources that support policy and programs to tailor to the needs of communities of people who inject. This tailoring is...

Australia’s Annual Report Card on STIs and blood-borne viruses

A

Kirby Institute, Monday, 6 November 2017 Gonorrhoea and syphilis diagnoses are increasing in Australia, HIV is stable, and more than 30,000 Australians have been cured of hepatitis C, according to the latest Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia, released today by the Kirby Institute at UNSW Sydney. The latest data shows that...

Hepatitis C cure leads to improved quality of life

H

hivandhepatitis.com, 23 October 2017
 People who were cured of hepatitis C with direct-acting antivirals (DAAs) had sustained improvements in their health-related quality of life, including both physical and mental health measures, according to study results presented at the 2017 AASLD Liver Meeting this week in Washington, DC.

Read more of Hepatitis C cure leads to improved quality of life

Australia leads the world in hepatitis C treatment – what’s behind its success?

A

The Conversation, July 31, 2017 4.05pm AEST The World Health Organisation recently set ambitious goals for the “elimination of hepatitis C as a major public health threat”. These included having 80% of people treated and an 80% reduction in the spread of the virus by 2030. Given there are around 70 million people infected with hep C worldwide, only 20% diagnosed, and no effective vaccine, the...

Your sidebar area is currently empty. Hurry up and add some widgets.